A carregar...

Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against Pseudomonas aeruginosa

A major contributor to fatalities in cystic fibrosis (CF) patients stems from infection with opportunistic bacterium Pseudomonas aeruginosa. As a result of the CF patient’s vulnerability to bacterial infections, one of the main treatment focuses is antibiotic therapy. However, the highly adaptive na...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Infect Dis
Main Authors: Hubble, Veronica B., Hubbard, Brittany A., Minrovic, Bradley M., Melander, Roberta J., Melander, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6716366/
https://ncbi.nlm.nih.gov/pubmed/30444345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.8b00288
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!